Results 1 - 10 of 259 : 1 2 3 4 5 6 7 8 9 Next
Looking to make a smart start? Consider these ideas.
Your portfolio's growth doesn't have to come from capital gains alone.
Will Patients Reject This Injection?
Wyeth and Progenics release good trial data, but will patients want their constipation drug?
The agency turns down another antibiotic.
Teva and AstraZeneca's Drama Concludes
But investors are still left in the dark.
Exelixis Has Friends With Cash
Bristol-Myers picks up one of the drugs from its collaboration.
It's the most important stock you can own.
A strategy to maximize your income.
Double Trouble for AstraZeneca
Generic woes and a miscue in the pipeline, oh my.
Depressing News for Drugmakers
Antidepressants aren't that different from each other, says a report.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK